Schwann cell transplantation: A repair strategy for spinal cord injury?

Ryan R. Wiliams, Mary B Bunge

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Schwann cells (SCs), when implanted in the injured spinal cord, support regeneration of axons, myelinate or ensheathe regenerated axons in a normal way, reduce cyst formation in the injured tissue, reduce secondary damage of tissue around the initial injury site, and modestly improve limb movements. If SC transplantation is combined with additional treatments such as methylprednisolone, neurotrophins, GDNF, olfactory ensheathing cells, chondroitinase, or elevation of cAMP levels, more axons (including those from neurons in the brainstem) regenerate into and out of the SC implant and further improve locomotion. Recent work to improve SC migration from the implant into the spinal cord by polysialylating NCAM on the SC surface has led to the novel finding that corticospinal axon growth is promoted by SCs. Recent studies are cited showing that when astrocytes extend slender processes into an implant instead of forming a sharp boundary they are permissive rather than inhibitory to axonal regrowth. The interfaces that comprise the " on-ramps" and the " off-ramps" are key to the success of a SC implant to span the injury site and to foster axon regeneration across the injury.

Original languageEnglish
Pages (from-to)295-312
Number of pages18
JournalProgress in Brain Research
Volume201
DOIs
StatePublished - Dec 3 2012

Fingerprint

Schwann Cells
Cell Transplantation
Spinal Cord Injuries
Axons
Architectural Accessibility
Wounds and Injuries
Chondroitinases and Chondroitin Lyases
Spinal Cord Regeneration
Glial Cell Line-Derived Neurotrophic Factor
Neural Cell Adhesion Molecules
Methylprednisolone
Nerve Growth Factors
Locomotion
Astrocytes
Brain Stem
Cell Movement
Cysts
Regeneration
Spinal Cord
Extremities

Keywords

  • Neurotrophins
  • PSA-NCAM
  • Reactive astrocytes
  • Schwann cell combination therapy
  • Schwann cell/astrocyte boundary assay
  • Schwann cell/spinal cord interface

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Schwann cell transplantation : A repair strategy for spinal cord injury? / Wiliams, Ryan R.; Bunge, Mary B.

In: Progress in Brain Research, Vol. 201, 03.12.2012, p. 295-312.

Research output: Contribution to journalArticle

Wiliams, Ryan R. ; Bunge, Mary B. / Schwann cell transplantation : A repair strategy for spinal cord injury?. In: Progress in Brain Research. 2012 ; Vol. 201. pp. 295-312.
@article{2d64bc44a5f844b1bf5ba0b373af4573,
title = "Schwann cell transplantation: A repair strategy for spinal cord injury?",
abstract = "Schwann cells (SCs), when implanted in the injured spinal cord, support regeneration of axons, myelinate or ensheathe regenerated axons in a normal way, reduce cyst formation in the injured tissue, reduce secondary damage of tissue around the initial injury site, and modestly improve limb movements. If SC transplantation is combined with additional treatments such as methylprednisolone, neurotrophins, GDNF, olfactory ensheathing cells, chondroitinase, or elevation of cAMP levels, more axons (including those from neurons in the brainstem) regenerate into and out of the SC implant and further improve locomotion. Recent work to improve SC migration from the implant into the spinal cord by polysialylating NCAM on the SC surface has led to the novel finding that corticospinal axon growth is promoted by SCs. Recent studies are cited showing that when astrocytes extend slender processes into an implant instead of forming a sharp boundary they are permissive rather than inhibitory to axonal regrowth. The interfaces that comprise the {"} on-ramps{"} and the {"} off-ramps{"} are key to the success of a SC implant to span the injury site and to foster axon regeneration across the injury.",
keywords = "Neurotrophins, PSA-NCAM, Reactive astrocytes, Schwann cell combination therapy, Schwann cell/astrocyte boundary assay, Schwann cell/spinal cord interface",
author = "Wiliams, {Ryan R.} and Bunge, {Mary B}",
year = "2012",
month = "12",
day = "3",
doi = "10.1016/B978-0-444-59544-7.00014-7",
language = "English",
volume = "201",
pages = "295--312",
journal = "Progress in Brain Research",
issn = "0079-6123",
publisher = "Elsevier",

}

TY - JOUR

T1 - Schwann cell transplantation

T2 - A repair strategy for spinal cord injury?

AU - Wiliams, Ryan R.

AU - Bunge, Mary B

PY - 2012/12/3

Y1 - 2012/12/3

N2 - Schwann cells (SCs), when implanted in the injured spinal cord, support regeneration of axons, myelinate or ensheathe regenerated axons in a normal way, reduce cyst formation in the injured tissue, reduce secondary damage of tissue around the initial injury site, and modestly improve limb movements. If SC transplantation is combined with additional treatments such as methylprednisolone, neurotrophins, GDNF, olfactory ensheathing cells, chondroitinase, or elevation of cAMP levels, more axons (including those from neurons in the brainstem) regenerate into and out of the SC implant and further improve locomotion. Recent work to improve SC migration from the implant into the spinal cord by polysialylating NCAM on the SC surface has led to the novel finding that corticospinal axon growth is promoted by SCs. Recent studies are cited showing that when astrocytes extend slender processes into an implant instead of forming a sharp boundary they are permissive rather than inhibitory to axonal regrowth. The interfaces that comprise the " on-ramps" and the " off-ramps" are key to the success of a SC implant to span the injury site and to foster axon regeneration across the injury.

AB - Schwann cells (SCs), when implanted in the injured spinal cord, support regeneration of axons, myelinate or ensheathe regenerated axons in a normal way, reduce cyst formation in the injured tissue, reduce secondary damage of tissue around the initial injury site, and modestly improve limb movements. If SC transplantation is combined with additional treatments such as methylprednisolone, neurotrophins, GDNF, olfactory ensheathing cells, chondroitinase, or elevation of cAMP levels, more axons (including those from neurons in the brainstem) regenerate into and out of the SC implant and further improve locomotion. Recent work to improve SC migration from the implant into the spinal cord by polysialylating NCAM on the SC surface has led to the novel finding that corticospinal axon growth is promoted by SCs. Recent studies are cited showing that when astrocytes extend slender processes into an implant instead of forming a sharp boundary they are permissive rather than inhibitory to axonal regrowth. The interfaces that comprise the " on-ramps" and the " off-ramps" are key to the success of a SC implant to span the injury site and to foster axon regeneration across the injury.

KW - Neurotrophins

KW - PSA-NCAM

KW - Reactive astrocytes

KW - Schwann cell combination therapy

KW - Schwann cell/astrocyte boundary assay

KW - Schwann cell/spinal cord interface

UR - http://www.scopus.com/inward/record.url?scp=84870152106&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870152106&partnerID=8YFLogxK

U2 - 10.1016/B978-0-444-59544-7.00014-7

DO - 10.1016/B978-0-444-59544-7.00014-7

M3 - Article

C2 - 23186720

AN - SCOPUS:84870152106

VL - 201

SP - 295

EP - 312

JO - Progress in Brain Research

JF - Progress in Brain Research

SN - 0079-6123

ER -